Two Cases of Mycosis Fungoides With PCM1-JAK2 Fusion-Reference-Cited by-同舟云学术

Two Cases of Mycosis Fungoides With PCM1-JAK2 Fusion

Published:2021-04 Issue:5 Volume: Page:646-652
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Fernandez-Pol Sebastian¹^ORCID,Neishaboori Nastaran¹,Chapman Courtney M.¹,Khodadoust Michael S.²^ORCID,Kim Youn H.³^ORCID,Rieger Kerri E.¹³^ORCID,Suarez Carlos J.¹^ORCID

Affiliation:

1. Department of Pathology, Stanford University School of Medicine, Stanford, CA

2. Department of Medicine, Stanford University School of Medicine, Stanford, CA

3. Department of Dermatology, Stanford University School of Medicine, Stanford, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00366

Reference14 articles.

1. Should myeloid and lymphoid neoplasms withPCM1-JAK2and other rearrangements ofJAK2be recognized as specific entities?

2. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

3. Hodgkin's Disease, Lymphomatoid Papulosis, and Cutaneous T-Cell Lymphoma Derived from a Common T-Cell Clone

4. t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive Form of Mycosis Fungoides With Bilateral Testicular Involvement and Salivary Gland Mass, Exhibiting Phenotypic Switch;The American Journal of Dermatopathology;2024-07-12

2. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

3. How molecular advances may improve the diagnosis and management of PTCL patients;Frontiers in Oncology;2023-06-23

4. PCM1::JAK2 fusion associates with an atypical form of mycosis fungoides;Virchows Archiv;2022-07-04

5. PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature;The Oncologist;2022-04-26